Literature DB >> 7768300

Antagonism of beta-adrenoceptor-mediated relaxations of human bronchial smooth muscle by carbachol.

N Watson1, H Magnussen, K F Rabe.   

Abstract

Activation of muscarinic M2 receptors has been suggested to account, in part, for the reduced relaxant potency of beta-adrenoceptor agonists in canine and guinea-pig tracheal smooth muscle pre-contracted with muscarinic agonists as compared to histamine. The aim of the present study was to determine whether the potency of isoprenaline is reduced in human bronchial ring preparations pre-contracted with carbachol as compared to histamine and whether activation of muscarinic M2 receptors contributes to this effect. Cumulative concentration-effect curves to isoprenaline were obtained in the absence and presence of muscarinic M2 receptor antagonism by methoctramine (0.3 microM) in bronchial ring preparations pre-contracted to equivalent isometric tensions with either histamine (10 microM) or carbachol (1 microM). The relaxant potency of isoprenaline was reduced in preparations pre-contracted with carbachol compared to histamine, but there was no significant effect of muscarinic M2 receptor antagonism on either the potency or maximal relaxation by isoprenaline. In conclusion, increased functional antagonism of beta-adrenoceptor-mediated relaxation by muscarinic agonists can be demonstrated in human bronchial smooth muscle, but muscarinic M2 receptors do not appear to contribute to this effect.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7768300     DOI: 10.1016/0014-2999(95)00048-p

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Functional interactions between muscarinic M2 receptors and 5-hydroxytryptamine (5-HT)4 receptors and beta 3-adrenoceptors in isolated oesophageal muscularis mucosae of the rat.

Authors:  R M Eglen; B Peelle; M T Pulido-Rios; E Leung
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

2.  Effects of RP 73401, a novel, potent and selective phosphodiesterase type 4 inhibitor, on contractility of human, isolated bronchial muscle.

Authors:  E Naline; Y Qian; C Advenier; D Raeburn; J A Karlsson
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

3.  Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials.

Authors:  Sarah Haney; Robert J Hancox
Journal:  Respir Res       Date:  2007-03-06

4.  Selective inhibition of histamine-evoked Ca2+ signals by compartmentalized cAMP in human bronchial airway smooth muscle cells.

Authors:  Philippa Dale; Victoria Head; Mark R Dowling; Colin W Taylor
Journal:  Cell Calcium       Date:  2017-12-15       Impact factor: 6.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.